Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Service Type, By Synthesis Type, By Animal Type, By Therapeutic Category, and By Region

Description

List of Tables

The veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 17.08 billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Service Type (In-House and Contract Outsourcing), By Synthesis Type, By Animal Type, By Therapeutic Category, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (VAPIs) are the biologically active substances in medicinal products used to treat, prevent, or diagnose diseases in animals. They are the core components responsible for the intended therapeutic effect. Veterinary active pharmaceutical ingredients (VAPIs) manufacturing is the complex, highly regulated process of synthesizing or extracting biologically active substances. This involves chemical synthesis, fermentation, or isolation from natural sources, followed by extensive purification and stringent quality control to ensure identity, potency, purity, and safety.

The manufacturing process of veterinary active pharmaceutical ingredients must adhere to rigorous good manufacturing practice (GMP) standards set by authorities like the FDA and EMA. The physiological differences between species, such as metabolic rates, digestive systems, and specific disease pathogens, also influence the design, synthesis, and purification of the API.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

In terms of service type, the in-house segment accounted for 64.32% of revenue share in 2024 due to the strong preference of major veterinary pharmaceutical companies to maintain control over their production processes.

Based on synthesis type, the chemical-based API segment held 72.34% of the revenue share in 2024. Chemical synthesis provided scalability, cost efficiency, and consistency, making it the preferred choice for manufacturing drugs that target common conditions in both livestock and companion animals.

In terms of animal type, the production animals segment accounted for 61.32% of revenue share in 2024 due to rising demand for meat, dairy, and poultry products.

Based on therapeutic category, the anti-infectives segment held the largest revenue share in 2024 due to the persistent threat of bacterial and viral diseases in companion and farm animals.

North America veterinary active pharmaceutical ingredients manufacturing market accounted for the largest revenue share in 2024. This dominance is attributed to rising companion animal ownership rates.

The industry in the Asia Pacific is projected to grow at the fastest pace in the coming years, owing to a growing middle-class population, increasing pet ownership, and rising spending on premium veterinary care.

A few global key market players include Alivira Animal Health Limited; AMGIS Lifescience Ltd.; Bimeda Inc.; Chempro Pharma Private Limited; Excel Industries Limited; FIS - Fabbrica Italiana Sintetici S.p.A.; Grupo Indukern S.L.; Huvepharma AD; Huateng Pharma; Menadiona S.L.; NGL Fine-Chem Ltd.; Ofichem Group B.V.; SUANFARMA S.A.; and Zoetis Inc.

Polaris Market Research has segmented the market report on the basis of service type, synthesis type, animal type, therapeutic category, and region:

By Service Type Outlook (Revenue, USD Billion, 2020-2034)

In House

Contract Outsourcing

Contract Development

Preclinical Development

Clinical Development

Contract Manufacturing

By Synthesis Type Mode Outlook (Revenue, USD Billion, 2020-2034)

Chemical-based API

Biological API

HPAPI

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

Production Animals

Companion Animals

By Therapeutic Category Outlook (Revenue, USD Billion, 2020-2034)

Antiparasitics

Anti-infectives

NSAIDs

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM4540

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Market Snapshot
4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Expenditure on Animal Health
  - 4.2.1.2. Increasing Investment in Facility Expansion
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Stringent Regulation
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
4.6. Value Chain Analysis

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
5.3. In House
- 5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In House, by Region, 2020-2034 (USD Billion)
5.4. Contract Outsourcing
- 5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2020-2034 (USD Billion)
- 5.4.2. Contract Development
  - 5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2020-2034 (USD Billion)
  - 5.4.2.2. Preclinical Development
  - 5.4.2.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
  - 5.4.2.3. Clinical Development
  - 5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2020-2034 (USD Billion)
- 5.4.3. Contract Manufacturing
  - 5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
6.3. Chemical-based API
- 6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2020-2034 (USD Billion)
6.4. Biological API
- 6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2020-2034 (USD Billion)
6.5. HPAPI
- 6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
7.3. Production Animals
- 7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2020-2034 (USD Billion)
7.4. Companion Animals
- 7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
8.3. Antiparasitics
- 8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitics, by Region, 2020-2034 (USD Billion)
8.4. Anti-infectives
- 8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
8.5. NSAIDs
- 8.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2020-2034 (USD Billion)
8.6. Others
- 8.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - North America
- 9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
- 9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
- 9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - US
  - 9.3.5.1. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Canada
  - 9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Europe
- 9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
- 9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
- 9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UK
  - 9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - France
  - 9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Germany
  - 9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Italy
  - 9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Spain
  - 9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Netherlands
  - 9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Russia
  - 9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.4.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Asia Pacific
- 9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - China
  - 9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - India
  - 9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Malaysia
  - 9.5.7.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Japan
  - 9.5.8.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Indonesia
  - 9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Korea
  - 9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Australia
  - 9.5.11.1. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.5.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UAE
  - 9.6.6.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Israel
  - 9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Africa
  - 9.6.8.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.6.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Latin America
- 9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Mexico
  - 9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Brazil
  - 9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Argentina
  - 9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
- 9.7.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Alivira Animal Health Limited
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. AMGIS Lifescience Ltd.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bimeda Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Chempro Pharma Private Limited
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Excel Industries Limited
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. FIS - Fabbrica Italiana Sintetici S.p.A.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Grupo Indukern S.L.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Huateng Pharma
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Huvepharma AD
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Menadiona S.L.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. NGL Fine-Chem Ltd.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Ofichem Group B.V.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. SUANFARMA S.A
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Zoetis Inc.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development